Israel Deutsch
Overview
Explore the profile of Israel Deutsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
770
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Horowitz D, Wang Y, Lee A, Riegel A, Pasetsky J, Elliston C, et al.
Pract Radiat Oncol
. 2025 Mar;
PMID: 40049229
Adaptive radiation therapy (ART) represents an evolution in the field of radiation oncology, addressing the complexities of tumor motion and anatomical variability that often challenge conventional treatment techniques. In abdominopelvic...
2.
Rayn K, Deutsch I, Jeffers B, Lee A, Lavrova E, Gallitto M, et al.
Adv Radiat Oncol
. 2024 Feb;
9(3):101408.
PMID: 38304110
Purpose: To maximize the therapeutic ratio, it is important to identify adverse prognostic features in men with prostate cancer, especially among those with intermediate risk disease, which represents a heterogeneous...
3.
Hahn N, ODonnell M, Efstathiou J, Zahurak M, Rosner G, Smith J, et al.
Eur Urol
. 2023 Jan;
83(6):486-494.
PMID: 36717286
Background: Novel treatments and trial designs remain a high priority for bacillus Calmette-Guerin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC) patients. Objective: To evaluate the safety and preliminary efficacy of anti-PD-L1 directed...
4.
Margolin E, Pina Martina L, Miles C, Wenske S, McKiernan J, DeCastro G, et al.
Urol Oncol
. 2021 Jun;
39(8):480-486.
PMID: 34092480
Purpose: The rapid expansion of telemedicine has presented a challenge for the care of patients with genitourinary malignancies. We sought to assess patient and physician perspectives on the use of...
5.
Hwang M, Mayeda M, Shaish H, Elliston C, Spina C, Wenske S, et al.
Br J Radiol
. 2021 Feb;
94(1119):20200433.
PMID: 33586999
Objective: We aim to test the hypothesis that neurovascular bundle (NVB) displacement by rectal hydrogel spacer combined with NVB delineation as an organ at risk (OAR) is a feasible method...
6.
Langevin S, Chang E, Wang T, Deutsch I, Otten M, Marr B
Ocul Oncol Pathol
. 2020 Apr;
6(2):93-98.
PMID: 32258016
Ocular melanocytosis has traditionally been associated with increased risk of developing uveal melanoma; however, rarely primary episcleral melanoma has been reported in the literature. Herein, we present the third case...
7.
Zhou Z, Kinslow C, Wang P, Huang B, Cheng S, Deutsch I, et al.
J Clin Med
. 2020 Jan;
9(1).
PMID: 31947882
Clear cell adenocarcinoma (CCA) is a rare variant of urinary bladder carcinoma with a glycogen-rich phenotype and unknown prognosis. Using the National Cancer Institute's surveillance, epidemiology, and end results (SEER)...
8.
Hwang M, Mayeda M, Liz M, Goode-Marshall B, Gonzalez L, Elliston C, et al.
Radiat Oncol
. 2019 Aug;
14(1):136.
PMID: 31375119
Background: Multiple phase I-II clinical trials have reported on the efficacy and safety of prostate stereotactic body radiotherapy (SBRT) for the treatment of prostate cancer. However, few have reported outcomes...
9.
Jones N, Huang Y, Chatterjee S, Tergas A, Burke W, Hou J, et al.
Int J Gynecol Cancer
. 2019 Feb;
29(2):365-376.
PMID: 30718315
Objective: For women with uterine cancer with metastases isolated to the adnexa (stage IIIA) optimal adjuvant therapy is unknown. We performed a population-based analysis to examine the use of chemotherapy,...
10.
Hwang M, Black P, Elliston C, Wolthuis B, Smith D, Wu C, et al.
Radiat Oncol
. 2018 Oct;
13(1):192.
PMID: 30285812
Background: The SpaceOAR hydrogel is employed to limit rectal radiation dose during prostate radiotherapy. We identified a novel parameter - the product of angle θ and hydrogel volume - to...